Tocilizumab Monotherapy As The First Line of Biological Treatment In Rheumatoid Arthritis- Budget Impact Analyses From The Perspective of Brazilian Public Healthcare System (SUS)
Abstract
Authors
LA Ramos TT Matsumoto C Rufino CS La Scala M Alves